3,073 Shares in Integer Holdings Co. (NYSE:ITGR) Purchased by AlphaMark Advisors LLC

AlphaMark Advisors LLC acquired a new position in Integer Holdings Co. (NYSE:ITGR) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 3,073 shares of the medical equipment provider’s stock, valued at approximately $359,000.

Several other institutional investors also recently bought and sold shares of ITGR. Vanguard Group Inc. lifted its stake in shares of Integer by 0.4% in the third quarter. Vanguard Group Inc. now owns 3,843,992 shares of the medical equipment provider’s stock worth $301,484,000 after buying an additional 15,300 shares in the last quarter. abrdn plc boosted its stake in Integer by 0.6% during the fourth quarter. abrdn plc now owns 520,646 shares of the medical equipment provider’s stock worth $51,586,000 after buying an additional 3,013 shares during the last quarter. Congress Asset Management Co. MA grew its holdings in Integer by 7.5% in the 1st quarter. Congress Asset Management Co. MA now owns 453,260 shares of the medical equipment provider’s stock valued at $52,886,000 after buying an additional 31,736 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of Integer by 0.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 382,936 shares of the medical equipment provider’s stock worth $37,941,000 after acquiring an additional 3,504 shares during the last quarter. Finally, Public Employees Retirement Association of Colorado raised its holdings in shares of Integer by 3,260.1% during the 4th quarter. Public Employees Retirement Association of Colorado now owns 285,439 shares of the medical equipment provider’s stock worth $28,281,000 after acquiring an additional 276,944 shares during the period. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on ITGR. Bank of America raised shares of Integer from a “neutral” rating to a “buy” rating and upped their price objective for the company from $105.00 to $135.00 in a report on Monday, April 15th. CL King started coverage on shares of Integer in a research report on Thursday, March 14th. They set a “buy” rating and a $137.00 price target on the stock. Benchmark reiterated a “buy” rating and issued a $130.00 price objective on shares of Integer in a research report on Friday, May 10th. Truist Financial started coverage on Integer in a research report on Wednesday, May 15th. They issued a “buy” rating and a $137.00 target price on the stock. Finally, KeyCorp upped their price target on Integer from $123.00 to $139.00 and gave the company an “overweight” rating in a research note on Tuesday, April 9th. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $128.00.

Insider Activity at Integer

In other news, Director James F. Hinrichs sold 9,603 shares of the business’s stock in a transaction dated Friday, May 24th. The stock was sold at an average price of $122.44, for a total value of $1,175,791.32. Following the completion of the sale, the director now directly owns 7,424 shares of the company’s stock, valued at approximately $908,994.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director James F. Hinrichs sold 9,603 shares of the firm’s stock in a transaction that occurred on Friday, May 24th. The shares were sold at an average price of $122.44, for a total transaction of $1,175,791.32. Following the transaction, the director now directly owns 7,424 shares in the company, valued at $908,994.56. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP John A. Harris sold 1,521 shares of the company’s stock in a transaction on Tuesday, June 4th. The shares were sold at an average price of $120.44, for a total transaction of $183,189.24. Following the completion of the sale, the executive vice president now owns 4,922 shares of the company’s stock, valued at approximately $592,805.68. The disclosure for this sale can be found here. Insiders have sold 17,936 shares of company stock valued at $2,130,937 in the last ninety days. Insiders own 2.00% of the company’s stock.

Integer Stock Down 0.5 %

Integer stock traded down $0.63 during midday trading on Monday, reaching $115.16. The company’s stock had a trading volume of 183,849 shares, compared to its average volume of 323,198. The company has a market cap of $3.86 billion, a P/E ratio of 39.85, a P/E/G ratio of 1.71 and a beta of 1.11. The company has a quick ratio of 2.01, a current ratio of 3.32 and a debt-to-equity ratio of 0.76. The business has a 50-day simple moving average of $116.86 and a 200-day simple moving average of $110.56. Integer Holdings Co. has a fifty-two week low of $69.40 and a fifty-two week high of $123.99.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share for the quarter, topping the consensus estimate of $1.12 by $0.02. The business had revenue of $414.80 million for the quarter, compared to analyst estimates of $412.78 million. Integer had a return on equity of 11.25% and a net margin of 6.01%. The business’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter last year, the company earned $0.87 EPS. On average, research analysts expect that Integer Holdings Co. will post 5.27 earnings per share for the current fiscal year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.